Your journey to publication continues here Discover why


  • Product nameAnti-PPAR gamma antibody
    See all PPAR gamma primary antibodies
  • Description
    Rabbit polyclonal to PPAR gamma
  • Specificitywill recognize both PPAR gamma1 and PPAR gamma2
  • Tested applicationsICC/IF, WBmore details
  • Species reactivity
    Reacts with: Mouse, Rat, Chicken, Hamster, Cow, Dog, Human, Pig
  • Immunogen

    Synthetic peptide (Human) (C terminal) from a region between AA 420 and 460 of the PPARgamma protein.

  • Positive control
    • Nuclear lysate of THP-1 cells stimulated with PMA. Incubate the THP-1 cells 10 ng/ml PMA for 24 hours.


Our Abpromise guarantee covers the use of ab19481 in the following tested applications.

The application notes include recommended starting dilutions; optimal dilutions/concentrations should be determined by the end user.

Application Abreviews Notes
ICC/IF 1/50 - 1/100. Fix with paraformaldehyde.
WB 1/400. Predicted molecular weight: 58 kDa.Can be blocked with PPAR gamma peptide (ab207794). Block in TBST with 5% w/v nonfat dry milk. The dilution was calculated using an Ecl detection method. With more sensitive detection kits the antibody may be used at much higher dilutions.


  • FunctionReceptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the receptor binds to a promoter element in the gene for acyl-CoA oxidase and activates its transcription. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis.
  • Tissue specificityHighest expression in adipose tissue. Lower in skeletal muscle, spleen, heart and liver. Also detectable in placenta, lung and ovary.
  • Involvement in diseaseNote=Defects in PPARG can lead to type 2 insulin-resistant diabetes and hyptertension. PPARG mutations may be associated with colon cancer.
    Defects in PPARG may be associated with susceptibility to obesity (OBESITY) [MIM:601665]. It is a condition characterized by an increase of body weight beyond the limitation of skeletal and physical requirements, as the result of excessive accumulation of body fat.
    Defects in PPARG are the cause of familial partial lipodystrophy type 3 (FPLD3) [MIM:604367]. Familial partial lipodystrophies (FPLD) are a heterogeneous group of genetic disorders characterized by marked loss of subcutaneous (sc) fat from the extremities. Affected individuals show an increased preponderance of insulin resistance, diabetes mellitus and dyslipidemia.
    Genetic variations in PPARG can be associated with susceptibility to glioma type 1 (GLM1) [MIM:137800]. Gliomas are central nervous system neoplasms derived from glial cells and comprise astrocytomas, glioblastoma multiforme, oligodendrogliomas, and ependymomas. Note=Polymorphic PPARG alleles have been found to be significantly over-represented among a cohort of American patients with sporadic glioblastoma multiforme suggesting a possible contribution to disease susceptibility.
  • Sequence similaritiesBelongs to the nuclear hormone receptor family. NR1 subfamily.
    Contains 1 nuclear receptor DNA-binding domain.
  • Cellular localizationNucleus.
  • Information by UniProt
  • Database links
  • Alternative names
    • CIMT1 antibody
    • GLM1 antibody
    • NR1C3 antibody
    • Nuclear receptor subfamily 1 group C member 3 antibody
    • OTTHUMP00000185032 antibody
    • OTTHUMP00000185036 antibody
    • Peroxisome proliferator activated nuclear receptor gamma variant 1 antibody
    • Peroxisome proliferator activated receptor gamma 1 antibody
    • Peroxisome Proliferator Activated Receptor gamma antibody
    • Peroxisome proliferator-activated receptor gamma antibody
    • PPAR gamma antibody
    • PPAR-gamma antibody
    • PPARG antibody
    • PPARG_HUMAN antibody
    • PPARG1 antibody
    • PPARG2 antibody
    • PPARgamma antibody
    see all

Anti-PPAR gamma antibody images

  • ab19481 staining PPARγ in U-87 MG cells treated with ciglitazone (ab141139), by ICC/IF. Increase of PPARγ cytoplasmic expression correlates with increased concentration of ciglitazone, as described in literature.
    The cells were incubated at 37°C for 24 hours in media containing different concentrations of ab141139 (ciglitazone) in DMSO, fixed with 4% formaldehyde for 10 minutes at room temperature and blocked with PBS containing 10% goat serum, 0.3 M glycine, 1% BSA and 0.1% tween for 2h at room temperature. Staining of the treated cells with ab19481 (5 μg/ml) was performed overnight at 4°C in PBS containing 1% BSA and 0.1% tween. A DyLight 488 anti-rabbit polyclonal antibody (ab96899) at 1/250 dilution was used as the secondary antibody. Nuclei were counterstained with DAPI and are shown in blue.
  • ab19481 staining CHO K1 cells expressing Human PPAR gamma by ICC/IF.  Cells were formaldehyde fixed and permeabilized in 0.1 % Triton X-100 prior to blocking with TBS + 3% Dried Milk + 0.1 % Triton X-100 for 20 minutes at 22°C.  The primary anitbody was diluted 1/50 and incubated with the sample for 1 hour at 22°C.  A FITC conjugated goat anti-rabbit antibody diluted 1/400 was used as the secondary.  The cells in the top image clearly show punctate cytoplasmic and nuclear localization of Human PPAR gamma when grown in the presence of F12 + 1.5% Charcoal/Dextran FBS.

    See Abreview

  • ICC/IF image of ab19481 stained HepG2 cells. The cells were 100% methanol fixed (5 min) and then incubated in 1%BSA / 10% normal goat serum / 0.3M glycine in 0.1% PBS-Tween for 1h to permeabilise the cells and block non-specific protein-protein interactions. The cells were then incubated with the antibody (ab19481, 1µg/ml) overnight at +4°C. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red) at a 1/200 dilution for 1h. DAPI was used to stain the cell nuclei (blue) at a concentration of 1.43µM.

References for Anti-PPAR gamma antibody (ab19481)

This product has been referenced in:
  • Nenicu A  et al. Combined blockade of angiotensin II type 1 receptor and activation of peroxisome proliferator-activated receptor-? by telmisartan effectively inhibits vascularization and growth of murine endometriosis-like lesions. Hum Reprod 29:1011-24 (2014). Read more (PubMed: 24578472) »
  • Li X  et al. A Network Pharmacology Study of Chinese Medicine QiShenYiQi to Reveal Its Underlying Multi-Compound, Multi-Target, Multi-Pathway Mode of Action. PLoS One 9:e95004 (2014). WB . Read more (PubMed: 24817581) »

See all 9 Publications for this product

Product Wall

Application Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)
Sample Mouse Tissue sections (Urothelium)
Antigen retrieval step Heat mediated - Buffer/Enzyme Used: Citric Acid pH 6
Permeabilization Yes - 0.1% Trypsin Treatment
Specification Urothelium
Blocking step Serum as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 10% · Temperature: RT°C
Fixative Paraformaldehyde

Abcam user community

Verified customer

Submitted Nov 02 2015

Dear Customer,

The product was delivered on April01. Fedex tracking number is 780417050225.

Hope it helps.


Dilce Madureira

Application Western blot
Loading amount 100 µg
Gel Running Conditions Reduced Denaturing (12%)
Sample Deer mouse (Peromyscus maniculatus) Tissue lysate - whole (White adipose tissue, Brown adipose tissue, Skelet)
Specification White adipose tissue, Brown adipose tissue, Skelet
Blocking step Milk as blocking agent for 12 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 4°C

Abcam user community

Verified customer

Submitted Dec 19 2014

Application Western blot
Loading amount 36 µg
Gel Running Conditions Reduced Denaturing (10%)
Sample Rat Tissue lysate - whole (Bone tissue (Tibia))
Specification Bone tissue (Tibia)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: RT°C

Mr. Helder Fonseca

Verified customer

Submitted Oct 08 2014

Thank you for your reply.
Yes, that is indeed strange. Unfortunately, I do not have a good explanation as to what could cause the antibody bind to the protein in this streaky way.
I was going to offer you a free of charge replacement as compe...

Read More

Thank you for submitting an Abreview of ab19481. As you may have noticed, your review has now been published on our website.
Since you obtained poor results using the antibody in a tested species and application, we would like to follow up on this...

Read More
Application Western blot
Sample Rat Tissue lysate - nuclear (Rat liver tissue)
Loading amount 50 µg
Specification Rat liver tissue
Gel Running Conditions Reduced Denaturing (10%)
Blocking step Milk as blocking agent for 1 hour(s) and 0 minute(s) · Concentration: 5% · Temperature: 25°C

Mrs. Smitha Koshy

Verified customer

Submitted Jul 25 2012

Thank you for confirming these details and for your cooperation. The details provided enable us to closely monitor the quality of our products.
I am sorry this product did not perform as stated on the datasheet and for the inconvenience this has c...

Read More

Thank you for taking time to complete our questionnaire. I am sorry to hear that this antibody is not providing satisfactory results.
The details provided will enable us to investigate this case and will provide us with vital information fo...

Read More

Thank you for your response.

Each antibody has specific storage buffer and recommended storage conditions. I would suggest checking this information carefully and follow the instructions. Generally, we suggest customers to use our antibodies ...

Read More